Latest Lead News

Polymetals Resources has officially commenced commercial production at its Endeavor silver zinc mine in Cobar, NSW, with zinc concentrate shipments set to begin in early July 2025. The company is progressing steadily toward ramping up output in the second half of the year.

Artrya Limited has submitted a pivotal FDA 510(k) application for its AI-powered Salix® Coronary Plaque module, aiming for clearance in Q3 2025 and a lucrative US commercial launch.

Nyrada’s Phase I clinical trial for its novel drug Xolatryp has cleared safety reviews through four cohorts and will now test higher doses and longer infusions in an expanded trial design.

Resouro Strategic Metals’ Tiros Project in Brazil has been selected for a major Brazilian government funding initiative aimed at advancing critical mineral production. This endorsement could accelerate the project’s development and bolster its role in the clean energy transition.

Adisyn Ltd has successfully completed a key R&D program on low-temperature graphene deposition, earning full approval and final payment of a $520,000 grant from the Israel Innovation Authority. This milestone validates its cutting-edge semiconductor technology aimed at revolutionizing AI and high-performance computing.

Enlitic, Inc. has launched a A$10 million placement alongside an offer of 125 million unquoted options, aiming to fuel growth in its AI-driven healthcare technology business. The move underscores both funding ambitions and the complex risks tied to AI adoption and market dynamics.

Ventia Services Group has locked in a $100 million, five-year contract with Tuatahi First Fibre, reinforcing its role as a key player in New Zealand's fibre infrastructure landscape.

Syntara Limited has unveiled encouraging interim Phase 2a data for SNT-5505, an add-on therapy targeting myelofibrosis patients with suboptimal response to ruxolitinib. The data highlight meaningful symptom relief and spleen volume reduction, positioning the drug as a potential game-changer in a challenging treatment landscape.

Cobre Limited has secured $500,000 through a placement and is now launching a fully underwritten Loyalty Options Rights Issue to raise approximately AU$1.18 million, supporting its capital-light, catalyst-rich copper exploration strategy in Botswana.

NH3 Clean Energy reports strong Pre-FEED results for its WAH2 clean ammonia project, highlighting robust economics and strategic partnerships while facing key risks around gas supply and funding.

Invion Limited launches a Loyalty Option entitlement offer aimed at raising up to $16 million to support its advancing cancer clinical trials, including a promising anogenital cancer study with Peter MacCallum Cancer Centre.

Saunders International announces the planned resignation of CEO Mark Benson by year-end alongside a notable downgrade in FY25 revenue and earnings guidance due to project delays and weather disruptions.